158 related articles for article (PubMed ID: 2848999)
1. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
[TBL] [Abstract][Full Text] [Related]
2. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
Cherney TM; Schultz RD
Am J Vet Res; 1996 Jun; 57(6):812-8. PubMed ID: 8725805
[TBL] [Abstract][Full Text] [Related]
3. [Immunization of young cattle with gp51 of the bovine leukosis virus and the subsequent experimental infection].
Burkhardt H; Rosenthal S; Wittmann W; Starick E; Scholz D; Rosenthal HA; Kluge KH
Arch Exp Veterinarmed; 1989 Nov; 43(6):933-42. PubMed ID: 2559673
[TBL] [Abstract][Full Text] [Related]
4. [Use of a monoclonal antibody against envelope protein gp51 of bovine leukemia virus in a test for the diagnosis of enzootic bovine leukosis].
Siakkou H; Platzer C; Beier D; Olechnowitz AF; Rosenthal S
Arch Exp Veterinarmed; 1990; 44(2):223-31. PubMed ID: 2167049
[TBL] [Abstract][Full Text] [Related]
5. A radioimmunoassay detecting the bovine leukaemia virus transmembrane protein gp30 and anti-gp30 antibodies in the serum of cattle.
Bossmann H; Siakkou H; Ulrich R; Uckert W; Kraft R; Rosenthal S; Rosenthal HA
Acta Virol; 1989 Mar; 33(2):113-20. PubMed ID: 2569806
[TBL] [Abstract][Full Text] [Related]
6. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
[TBL] [Abstract][Full Text] [Related]
7. Cross-reactive antibodies to BLV and HTLV in bovine and human hosts with retrovirus infection.
Maruyama K; Fukushima T; Mochizuki S
Vet Immunol Immunopathol; 1989 Oct; 22(3):265-73. PubMed ID: 2560858
[TBL] [Abstract][Full Text] [Related]
8. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
[TBL] [Abstract][Full Text] [Related]
11. Antibody production against BLV-p24 in calves following application of cell extracts from tumorous lymph nodes of cattle with enzootic bovine leukosis.
Ristau E; Starick E; Burkardt H; Wittmann W
Acta Virol; 1988 Mar; 32(2):104-8. PubMed ID: 2899956
[TBL] [Abstract][Full Text] [Related]
12. Identification of an immunodominant region on the isolated bovine leukaemia virus (BLV) major envelope protein gp51 by monoclonal antibodies presumably not exposed during natural BLV infection.
Platzer C; Siakkou H; Sober J; Kopp J; Scheve E; Rosenthal S
Acta Virol; 1990 May; 34(3):246-55. PubMed ID: 1980398
[TBL] [Abstract][Full Text] [Related]
13. Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.
Portetelle D; Mammerickx M; Burny A
J Virol Methods; 1989 Feb; 23(2):211-22. PubMed ID: 2542354
[TBL] [Abstract][Full Text] [Related]
14. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine.
Altaner C; Ban J; Altanerova V; Janik V
Vaccine; 1991 Dec; 9(12):889-95. PubMed ID: 1667347
[TBL] [Abstract][Full Text] [Related]
15. Bovine leukemia virus-gp51 antigen expression is associated with CD5 and IgM markers on infected lymphocytes.
Meirom R; Moss S; Brenner J
Vet Immunol Immunopathol; 1997 Oct; 59(1-2):113-9. PubMed ID: 9437829
[TBL] [Abstract][Full Text] [Related]
16. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51.
Portetelle D; Couez D; Bruck C; Kettmann R; Mammerickx M; Van der Maaten M; Brasseur R; Burny A
Virology; 1989 Mar; 169(1):27-33. PubMed ID: 2466370
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
[TBL] [Abstract][Full Text] [Related]
18. BLV receptor activity in plasma membranes from tumorous lymph nodes of BLV-infected cows.
Ristau E; Roessler H; Burkardt H; Scholz D; Rosenthal S
Acta Virol; 1986 Nov; 30(6):449-56. PubMed ID: 2881463
[TBL] [Abstract][Full Text] [Related]
19. Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.
Merza M; Söber J; Sundquist B; Toots I; Morein B
Arch Virol; 1991; 120(3-4):219-31. PubMed ID: 1720302
[TBL] [Abstract][Full Text] [Related]
20. Bovine leucosis virus challenge infection of calves following application of BL-3 cells.
Ristau E; Wittmann W; Starick E; Kluge KH
Arch Exp Veterinarmed; 1989 Jan; 43(1):155-8. PubMed ID: 2549903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
